Literature DB >> 24456424

MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.

Aladim Gomes Lameira1, Flávia Sirotheau Corrêa Pontes, Douglas Magno Guimarães, Ana Carolina Garcia Alves, Adriana Souza de Jesus, Hélder Antônio Rebelo Pontes, Décio Dos Santos Pinto.   

Abstract

BACKGROUND: The aim of this study was to identify the expression of MCM3, Ki-67 and p27 in normal mucosa, leucoplakia and oral squamous cell carcinoma (OSCC) and determine whether altered expression could serve as a prognostic marker of a malignant progression of dysplastic lesions.
METHODS: The samples were collected from 37 patients with oral leucoplakia (13 with mild dysplasia - MLD, 12 with moderate dysplasia - MD and 12 with severe dysplasia - SD). Eleven samples of mouth floor mucocele (M) and 50 floor mouth and tongue samples OSCC of untreated patients were included in this study. Immunohistochemical expression of MCM3, Ki-67 and p27 of all the groups was analysed. Kruskal-Wallis and Dunn's test were used to determine differences among groups, and a Pearson's correlation test was used to evaluate the correlation between the proteins.
RESULTS: Ki-67 expression was higher in OSCC than M (P < 0.001) and MLD (P < 0.01) groups, and there was a lower expression in M compared with MD and SD (P < 0.05). Regarding p27, its expression was lower in OSCC compared with M, MD and SD. MCM3 expression was lower in M compared with SD and OSCC (P < 0.001), and MLD showed a lower expression when compared SD (P < 0.01) and OSCC (P < 0.001). Moreover, a better correlation was observed between the proteins MCM3 and p27 than between Ki-67 and p27 proteins when all lesions were examined together.
CONCLUSIONS: This study showed that MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Ki-67; MCM3; leucoplakia; oral cancer; p27

Mesh:

Substances:

Year:  2014        PMID: 24456424     DOI: 10.1111/jop.12153

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

1.  MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.

Authors:  Eun Young Kang; Joshua Millstein; Gordana Popovic; Nicola S Meagher; Adelyn Bolithon; Aline Talhouk; Derek S Chiu; Michael S Anglesio; Betty Leung; Katrina Tang; Neil Lambie; Marina Pavanello; Annalyn Da-Anoy; Diether Lambrechts; Liselore Loverix; Siel Olbrecht; Christiani Bisinotto; Jesus Garcia-Donas; Sergio Ruiz-Llorente; Monica Yagüe-Fernandez; Robert P Edwards; Esther Elishaev; Alexander Olawaiye; Sarah Taylor; Beyhan Ataseven; Andreas du Bois; Philipp Harter; Jenny Lester; Claus K Høgdall; Sebastian M Armasu; Yajue Huang; Robert A Vierkant; Chen Wang; Stacey J Winham; Sabine Heublein; Felix K F Kommoss; Daniel W Cramer; Naoko Sasamoto; Lilian van-Wagensveld; Maria Lycke; Constantina Mateoiu; Janine Joseph; Malcolm C Pike; Kunle Odunsi; Chiu-Chen Tseng; Celeste L Pearce; Sanela Bilic; Thomas P Conrads; Arndt Hartmann; Alexander Hein; Michael E Jones; Yee Leung; Matthias W Beckmann; Matthias Ruebner; Minouk J Schoemaker; Kathryn L Terry; Mona A El-Bahrawy; Penny Coulson; John L Etter; Katherine LaVigne-Mager; Juergen Andress; Marcel Grube; Anna Fischer; Nina Neudeck; Greg Robertson; Rhonda Farrell; Ellen Barlow; Carmel Quinn; Anusha Hettiaratchi; Yovanni Casablanca; Ramona Erber; Colin J R Stewart; Adeline Tan; Yu Yu; Jessica Boros; Alison H Brand; Paul R Harnett; Catherine J Kennedy; Nikilyn Nevins; Terry Morgan; Peter A Fasching; Ignace Vergote; Anthony J Swerdlow; Francisco J Candido Dos Reis; G Larry Maxwell; Susan L Neuhausen; Arantzazu Barquin-Garcia; Francesmary Modugno; Kirsten B Moysich; Philip J Crowe; Akira Hirasawa; Florian Heitz; Beth Y Karlan; Ellen L Goode; Peter Sinn; Hugo M Horlings; Estrid Høgdall; Karin Sundfeldt; Stefan Kommoss; Annette Staebler; Anna H Wu; Paul A Cohen; Anna DeFazio; Cheng-Han Lee; Helen Steed; Nhu D Le; Simon A Gayther; Kate Lawrenson; Paul D P Pharoah; Gottfried Konecny; Linda S Cook; Susan J Ramus; Linda E Kelemen; Martin Köbel
Journal:  Virchows Arch       Date:  2021-11-15       Impact factor: 4.535

2.  The sonic hedgehog signaling pathway contributes to the development of salivary gland neoplasms regardless of perineural infiltration.

Authors:  Manuela Torres Andion Vidal; Sílvia Vanessa Lourenço; Fernando Augusto Soares; Clarissa Araújo Gurgel; Eduardo J B Studart; Ludmila de Faro Valverde; Iguaracyra Barreto de Oliveira Araújo; Eduardo Antônio Gonçalves Ramos; Flávia Caló de Aquino Xavier; Jean Nunes Dos Santos
Journal:  Tumour Biol       Date:  2016-01-21

Review 3.  MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.

Authors:  Zhikun Liu; Jie Li; Jun Chen; Qiaonan Shan; Haojiang Dai; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

4.  Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders.

Authors:  Gargi S Sarode; Sachin C Sarode; Nikunj Maniyar; Nilesh Sharma; Sujata Yerwadekar; Shankargouda Patil
Journal:  Oncol Rev       Date:  2019-09-10

5.  Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma.

Authors:  Andrzej Pyra; Aneta Adamiak-Godlewska; Dorota Lewkowicz; Beata Bałon; Marek Cybulski; Anna Semczuk-Sikora; Andrzej Semczuk
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

6.  MCM3 and Ki67 proliferation markers in odontogenic cysts and ameloblastoma.

Authors:  Zohreh Jaafari-Ashkavandi; Fatemeh Mehranmehr; Elham Roosta
Journal:  J Oral Biol Craniofac Res       Date:  2018-09-06

7.  Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations with Clinical and Histopathological Patterns.

Authors:  Ramón Gil Carreón-Burciaga; Rogelio González-González; Nelly Molina-Frechero; Ronell Bologna-Molina
Journal:  Dis Markers       Date:  2015-12-28       Impact factor: 3.434

8.  Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.

Authors:  Lin Cheng; Zhangmin Tan; Zenan Huang; Yuhang Pan; Wenhui Zhang; Jiani Wang
Journal:  Med Sci Monit       Date:  2020-08-24

9.  Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.

Authors:  Gurjeet Kaur; Shandra Devi Balasubramaniam; Yung Jen Lee; Venugopal Balakrishnan; Chern Ein Oon
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.